GGrantIndex
← Search

A PHASE 2 TRIAL OF NAB-SIROLIMUS IN PATIENTS WITH PROGRESSING OR SYMPTOMATIC EPITHELIOID HEMANGIOENDOTHELIOMA

$3,238,909FY2025Defense Health AgencyDOD

Sarc, Ann Arbor MI

Investigators

View source on USAspending →
A PHASE 2 TRIAL OF NAB-SIROLIMUS IN PATIENTS WITH PROGRESSING OR SYMPTOMATIC EPITHELIOID HEMANGIOENDOTHELIOMA · GrantIndex